Advanced Biomed Inc. ADVB
NASDAQ
| 06/30/2026 | 03/31/2026 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -3.38M | -3.38M | -3.26M |
| Total Depreciation and Amortization | -- | -- | 101.60K | 234.00K | 155.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -1.56M | 2.21M | -1.56M |
| Change in Net Operating Assets | -- | -- | -1.57M | -5.47M | -1.17M |
| Cash from Operations | -- | -- | -6.41M | -6.41M | -5.83M |
| Capital Expenditure | -- | -- | 18.20K | -13.40K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -31.70K | -- | -31.70K |
| Cash from Investing | -- | -- | -13.40K | -13.40K | -31.60K |
| Total Debt Issued | -- | -- | 652.10K | 1.32M | 602.70K |
| Total Debt Repaid | -- | -- | -8.90K | -847.70K | 2.30K |
| Issuance of Common Stock | -- | -- | 5.60M | 11.10M | 5.60M |
| Repurchase of Common Stock | -- | -- | -108.60K | -- | -108.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -147.70K | -5.58M | -164.50K |
| Cash from Financing | -- | -- | 5.99M | 5.99M | 5.93M |
| Foreign Exchange rate Adjustments | -- | -- | 439.50K | 439.50K | 218.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 9.50K | 9.50K | 295.90K |